1 active not recruiting, 1 completed, 1 recruiting, 1 terminated. 4 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 4 | Active not recruiting 1, Completed 1, Recruiting 1, Terminated 1 |
Follow ribociclib: new trials by email Literature Review of ribociclib trials Research Report on ribociclib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Novel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma CDK4/6 Inhibitor (Palbociclib, Ribociclib, Abemaciclib) - Medulloblastoma, Childhood | Early Phase 1 | Recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 60 | 2024-11-25 | 2026-09-03 |
| A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection Ribociclib, Everolimus - Glioblastoma Multiforme, Glioma of Brain | Early Phase 1 | Completed | St. Joseph's Hospital and Medical Center, Phoenix | 27 | 2019-01-19 | 2025-05-30 |
| Impact of Ribociclib on Head and Neck Squamous Cell Cancer Ribociclib - Squamous Cell Carcinoma of the Head and Neck | Early Phase 1 | Terminated | Fox Chase Cancer Center | 1 | 2018-04-02 | 2019-02-25 |
| Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients Ribociclib - Glioblastoma Multiforme, Meningioma | Early Phase 1 | Active not recruiting | Nader Sanai | 48 | 2016-10-17 | 2026-03-06 |
Glioblastoma (2) · Brain Neoplasms (1) · Glioma (1) · Medulloblastoma (1) · Meningioma (1) · Squamous Cell Carcinoma of Head and Neck (1)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · Fox Chase Cancer Center (1) · Nader Sanai (1) · St. Joseph's Hospital and Medical Center, Phoenix (1)
United States (3) · Italy (1)
Nader Sanai, MD (2) · Jessica Bauman, MD (1)